Vaccination

Politics affect public buy-in on COVID-19 vaccine, study shows

Public confidence in the safety and efficacy of a coronavirus vaccine will depend heavily on the political context in which a potential vaccine is approved and distributed, according to a new study by Yale researchers. 

Diseases, Conditions, Syndromes

Major COVID-19 vaccine trial resumes in UK after safety review

Pharma giant AstraZeneca and Oxford University on Saturday said they had resumed a COVID-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.

page 5 from 6